500 related articles for article (PubMed ID: 22417655)
1. FT011, a new anti-fibrotic drug, attenuates fibrosis and chronic heart failure in experimental diabetic cardiomyopathy.
Zhang Y; Edgley AJ; Cox AJ; Powell AK; Wang B; Kompa AR; Stapleton DI; Zammit SC; Williams SJ; Krum H; Gilbert RE; Kelly DJ
Eur J Heart Fail; 2012 May; 14(5):549-62. PubMed ID: 22417655
[TBL] [Abstract][Full Text] [Related]
2. A new anti-fibrotic drug attenuates cardiac remodeling and systolic dysfunction following experimental myocardial infarction.
Zhang Y; Elsik M; Edgley AJ; Cox AJ; Kompa AR; Wang B; Tan CY; Khong FL; Stapleton DI; Zammit S; Williams SJ; Gilbert RE; Krum H; Kelly DJ
Int J Cardiol; 2013 Sep; 168(2):1174-85. PubMed ID: 23219315
[TBL] [Abstract][Full Text] [Related]
3. FT23, an orally active antifibrotic compound, attenuates structural and functional abnormalities in an experimental model of diabetic cardiomyopathy.
Tan SM; Zhang Y; Wang B; Tan CY; Zammit SC; Williams SJ; Krum H; Kelly DJ
Clin Exp Pharmacol Physiol; 2012 Aug; 39(8):650-6. PubMed ID: 22612418
[TBL] [Abstract][Full Text] [Related]
4. Functional, structural and molecular aspects of diastolic heart failure in the diabetic (mRen-2)27 rat.
Connelly KA; Kelly DJ; Zhang Y; Prior DL; Martin J; Cox AJ; Thai K; Feneley MP; Tsoporis J; White KE; Krum H; Gilbert RE
Cardiovasc Res; 2007 Nov; 76(2):280-91. PubMed ID: 17716638
[TBL] [Abstract][Full Text] [Related]
5. Transplantation of bone marrow-derived endothelial progenitor cells attenuates myocardial interstitial fibrosis and cardiac dysfunction in streptozotocin-induced diabetic rats.
Cheng Y; Guo S; Liu G; Feng Y; Yan B; Yu J; Feng K; Li Z
Int J Mol Med; 2012 Oct; 30(4):870-6. PubMed ID: 22859217
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of protein kinase C-beta by ruboxistaurin preserves cardiac function and reduces extracellular matrix production in diabetic cardiomyopathy.
Connelly KA; Kelly DJ; Zhang Y; Prior DL; Advani A; Cox AJ; Thai K; Krum H; Gilbert RE
Circ Heart Fail; 2009 Mar; 2(2):129-37. PubMed ID: 19808328
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy.
Westermann D; Van Linthout S; Dhayat S; Dhayat N; Schmidt A; Noutsias M; Song XY; Spillmann F; Riad A; Schultheiss HP; Tschöpe C
Basic Res Cardiol; 2007 Nov; 102(6):500-7. PubMed ID: 17909696
[TBL] [Abstract][Full Text] [Related]
8. Curcumin prevents diabetic cardiomyopathy in streptozotocin-induced diabetic rats: possible involvement of PKC-MAPK signaling pathway.
Soetikno V; Sari FR; Sukumaran V; Lakshmanan AP; Mito S; Harima M; Thandavarayan RA; Suzuki K; Nagata M; Takagi R; Watanabe K
Eur J Pharm Sci; 2012 Oct; 47(3):604-14. PubMed ID: 22564708
[TBL] [Abstract][Full Text] [Related]
9. Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy.
Van Linthout S; Seeland U; Riad A; Eckhardt O; Hohl M; Dhayat N; Richter U; Fischer JW; Böhm M; Pauschinger M; Schultheiss HP; Tschöpe C
Basic Res Cardiol; 2008 Jul; 103(4):319-27. PubMed ID: 18347835
[TBL] [Abstract][Full Text] [Related]
10. Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene.
Tschöpe C; Walther T; Königer J; Spillmann F; Westermann D; Escher F; Pauschinger M; Pesquero JB; Bader M; Schultheiss HP; Noutsias M
FASEB J; 2004 May; 18(7):828-35. PubMed ID: 15117887
[TBL] [Abstract][Full Text] [Related]
11. A purpose-synthesised anti-fibrotic agent attenuates experimental kidney diseases in the rat.
Gilbert RE; Zhang Y; Williams SJ; Zammit SC; Stapleton DI; Cox AJ; Krum H; Langham R; Kelly DJ
PLoS One; 2012; 7(10):e47160. PubMed ID: 23071743
[TBL] [Abstract][Full Text] [Related]
12. Argatroban Attenuates Diabetic Cardiomyopathy in Rats by Reducing Fibrosis, Inflammation, Apoptosis, and Protease-Activated Receptor Expression.
Bulani Y; Sharma SS
Cardiovasc Drugs Ther; 2017 Jun; 31(3):255-267. PubMed ID: 28695302
[TBL] [Abstract][Full Text] [Related]
13. Myocardial hypertrophy and enhanced left ventricular contractility in Zucker diabetic fatty rats.
Fredersdorf S; Thumann C; Ulucan C; Griese DP; Luchner A; Riegger GA; Kromer EP; Weil J
Cardiovasc Pathol; 2004; 13(1):11-9. PubMed ID: 14761780
[TBL] [Abstract][Full Text] [Related]
14. 3',4'-Dihydroxyflavonol antioxidant attenuates diastolic dysfunction and cardiac remodeling in streptozotocin-induced diabetic m(Ren2)27 rats.
Khong FL; Zhang Y; Edgley AJ; Qi W; Connelly KA; Woodman OL; Krum H; Kelly DJ
PLoS One; 2011; 6(7):e22777. PubMed ID: 21829510
[TBL] [Abstract][Full Text] [Related]
15. Allopurinol attenuates left ventricular dysfunction in rats with early stages of streptozotocin-induced diabetes.
Gao X; Xu Y; Xu B; Liu Y; Cai J; Liu HM; Lei S; Zhong YQ; Irwin MG; Xia Z
Diabetes Metab Res Rev; 2012 Jul; 28(5):409-17. PubMed ID: 22389139
[TBL] [Abstract][Full Text] [Related]
16. Cardiac remodeling rather than disturbed myocardial energy metabolism is associated with cardiac dysfunction in diabetic rats.
Bollano E; Omerovic E; Svensson H; Waagstein F; Fu M
Int J Cardiol; 2007 Jan; 114(2):195-201. PubMed ID: 21882490
[TBL] [Abstract][Full Text] [Related]
17. FT011, a Novel Cardiorenal Protective Drug, Reduces Inflammation, Gliosis and Vascular Injury in Rats with Diabetic Retinopathy.
Deliyanti D; Zhang Y; Khong F; Berka DR; Stapleton DI; Kelly DJ; Wilkinson-Berka JL
PLoS One; 2015; 10(7):e0134392. PubMed ID: 26222724
[TBL] [Abstract][Full Text] [Related]
18. Antioxidant treatment attenuates hyperglycemia-induced cardiomyocyte death in rats.
Fiordaliso F; Bianchi R; Staszewsky L; Cuccovillo I; Doni M; Laragione T; Salio M; Savino C; Melucci S; Santangelo F; Scanziani E; Masson S; Ghezzi P; Latini R
J Mol Cell Cardiol; 2004 Nov; 37(5):959-68. PubMed ID: 15522273
[TBL] [Abstract][Full Text] [Related]
19. Preservation of ventricular performance at early stages of diabetic cardiomyopathy involves changes in myocyte size, number and intercellular coupling.
Stilli D; Lagrasta C; Berni R; Bocchi L; Savi M; Delucchi F; Graiani G; Monica M; Maestri R; Baruffi S; Rossi S; Macchi E; Musso E; Quaini F
Basic Res Cardiol; 2007 Nov; 102(6):488-99. PubMed ID: 17585379
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effects of neuregulin-1 in diabetic cardiomyopathy rats.
Li B; Zheng Z; Wei Y; Wang M; Peng J; Kang T; Huang X; Xiao J; Li Y; Li Z
Cardiovasc Diabetol; 2011 Jul; 10():69. PubMed ID: 21798071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
